1. Home
  2. SLNO vs CBU Comparison

SLNO vs CBU Comparison

Compare SLNO & CBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • CBU
  • Stock Information
  • Founded
  • SLNO 1999
  • CBU 1866
  • Country
  • SLNO United States
  • CBU United States
  • Employees
  • SLNO N/A
  • CBU N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CBU Major Banks
  • Sector
  • SLNO Health Care
  • CBU Finance
  • Exchange
  • SLNO Nasdaq
  • CBU Nasdaq
  • Market Cap
  • SLNO 3.2B
  • CBU 2.8B
  • IPO Year
  • SLNO 2014
  • CBU N/A
  • Fundamental
  • Price
  • SLNO $73.35
  • CBU $56.29
  • Analyst Decision
  • SLNO Strong Buy
  • CBU Buy
  • Analyst Count
  • SLNO 9
  • CBU 3
  • Target Price
  • SLNO $103.33
  • CBU $71.00
  • AVG Volume (30 Days)
  • SLNO 744.8K
  • CBU 174.4K
  • Earning Date
  • SLNO 05-07-2025
  • CBU 07-22-2025
  • Dividend Yield
  • SLNO N/A
  • CBU 3.27%
  • EPS Growth
  • SLNO N/A
  • CBU 16.34
  • EPS
  • SLNO N/A
  • CBU 3.61
  • Revenue
  • SLNO N/A
  • CBU $741,961,000.00
  • Revenue This Year
  • SLNO N/A
  • CBU $14.01
  • Revenue Next Year
  • SLNO N/A
  • CBU $8.95
  • P/E Ratio
  • SLNO N/A
  • CBU $15.57
  • Revenue Growth
  • SLNO N/A
  • CBU 7.37
  • 52 Week Low
  • SLNO $36.93
  • CBU $42.16
  • 52 Week High
  • SLNO $80.99
  • CBU $73.39
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 49.78
  • CBU 49.24
  • Support Level
  • SLNO $72.29
  • CBU $55.87
  • Resistance Level
  • SLNO $78.32
  • CBU $57.01
  • Average True Range (ATR)
  • SLNO 2.74
  • CBU 1.09
  • MACD
  • SLNO -0.57
  • CBU -0.14
  • Stochastic Oscillator
  • SLNO 27.11
  • CBU 30.54

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About CBU Community Bank System Inc.

Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional and governmental customers. The Company also offers comprehensive financial planning, trust administration and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services and Wealth Management Services.

Share on Social Networks: